Current understanding of sepsis

Clinical Infectious Diseases

Volumn 22, Issue 3, 1996, Pages 407-413

  Wenzel, Richard P ^a   Pinsky, Michael R ^b   Ulevitch, Richard J ^b   Young, Lowell ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTEREMIA; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CANDIDA; CANDIDIASIS; CLINICAL FEATURE; HOSPITAL INFECTION; HUMAN; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; SEPSIS; SEPTIC SHOCK;

EID: 0029759278     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/22.3.407     Document Type: Review

References (20)

1. Wenzel RP. Anti-endotoxin monoclonal antibodies - a second look. N Eng J Med 1992;326:1151-3.
2. Centers for Disease Control and Prevention, National Center for Health Statistics. Mortality patterns-United States, 1990. Monthly Vital Statistics Report 1993;41:5.
3. Rose R, Hunting KJ, Townsend TR, Wenzel RP. Morbidity/mortality and economics of hospital-acquired bloodstream infections: a controlled study. South Med J 1977;70:1267-9.
4. Townsend TR, Wenzel RP. Nosocomial bloodstream infections in a new-born intensive care unit: a case-matched control study of morbidity, mortality, and risk. Am J Epidemiol 1984;114:73-80.
5. Spengler RF, Greenough WE III. Hospital costs and mortality attributed to nosocomial bacteremias. JAMA 1978;240:455-8.
6. Landry SL, Kaiser DL, Wenzel RP. Hospital stay and mortality attributed to nosocomial enterococcal bacteremia: a controlled study. Am J Infect Control 1989;17:323-9.
7. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med 1988;148:2642-5.
8. Martin MA, Pfaller MA, Wenzel RP. Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay. Ann Intern Med 1989;110:9-16.
9. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. JAMA 1994;271:1598-1601.
10. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-74.
11. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). JAMA 1995;273:117-23.
12. Pinsky MR. Cause-specific management of shock. Postgrad Med 1983; 73:127-35, 138-40, 145.
13. Vincent JL, Gris P, Coffernils M, et al. Myocardial depression characterizes the fatal course of septic shock. Surgery 1992;111:660-7.
14. Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T. The complex pattern of cytokines in serum of patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 1989;169:333-8.
15. Movat HZ, Cybulsky MI, Colditz IG, Chan MK, Dinarello CA. Acute inflammation in gram-negative infection: endotoxin, interleukin 1, tumor necrosis factor, and neutrophils. Fed Proc 1987;46:97-104.
16. Waage A, Halstensen A, Espevik T. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987;1:355-7.
17. Hack CE, De Groot ER, Felt-Borsma RJ, et al. Increased plasma levels of interleukin-6 in sepsis. Blood 1989;74:1704-10.
18. Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 1993;103:565-75.
19. Bell RC, Coalson JJ, Smith JD, Johanson WG Jr. Multiple organ system failure and infection in adult respiratory distress syndrome. Ann Intern Med 1983;99:293-8.
20. Montgomery AB, Stager MA, Carrico CJ, Hudson LD. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1985;132:485-9.